Marker Therapeutics, Inc. 8-K

What Happened

• Marker Therapeutics, Inc. (MRKR) filed an 8-K on February 9, 2026 announcing it scheduled its 2026 Annual Meeting of Stockholders for May 1, 2026.
• Because the meeting date moved by more than 30 days from the anniversary of the 2025 meeting, the company set a new deadline under SEC rules for stockholder proposals to be included in its proxy materials.

Key Details

• 2026 Annual Meeting date: May 1, 2026.
• Deadline for shareholder proposals (to be included in the proxy statement under Rule 14a‑8): March 9, 2026.
• Proposals or nominations must be delivered to: Marker Therapeutics, Inc., Attn: Corporate Secretary, 2450 Holcombe Blvd, TMC Partners Office 1.311, Houston, Texas 77021.
• The meeting record date, time and location will be disclosed in the company’s 2026 proxy statement.

Why It Matters

• Shareholders who want to submit proposals or nominate directors for inclusion in Marker’s 2026 proxy must meet the March 9 deadline and follow the delivery instructions; missing it could mean proposals are not included in the company’s official proxy materials.
• The change in meeting date affects the timeline for proxy distribution and any investor planning to engage the company ahead of the meeting should note the new schedule.